Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem

Vertex Pharmaceuticals Inc. (VRTX) announced Tuesday that it has obtained an exclusive license from TreeFrog Therapeutics, a French-based biotech company, to its proprietary cell manufacturing technology, C-Stem, to optimize production of Vertex's cell therapies for type 1 diabetes or T1D.